We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.2M
AUM Growth
+$10.1M
(+13%)
Cap. Flow
+$4.72M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
114
New
6
Increased
84
Reduced
17
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$801K |
| 2 |
InMode
INMD
|
+$412K |
| 3 |
Abbott
ABT
|
+$402K |
| 4 |
Robert Half
RHI
|
+$266K |
| 5 |
Comcast
CMCSA
|
+$266K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$749K |
| 2 |
Corpay
CPAY
|
+$635K |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$622K |
| 4 |
AMN Healthcare
AMN
|
+$407K |
| 5 |
KeyCorp
KEY
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.82% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 10.23% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Merck
MRK
$315B
| $412K | 0.47% |
3,875
+297
| +8% | +$32.1K |
|
77
PNC Financial Services
PNC
$100B
| $405K | 0.46% |
3,189
+136
| +4% | +$20.5K |
|
78
ConocoPhillips
COP
$145B
| $401K | 0.45% |
4,039
+352
| +10% | +$38.5K |
|
79
State Street
STT
$50.1B
| $389K | 0.44% |
5,140
-52
| -1% | -$4.38K |
|
80
Eaton
ETN
$169B
| $384K | 0.44% |
2,239
-50
| -2% | -$8.32K |
|
|
81
InMode
INMD
$881M
| $384K | 0.44% |
+12,020
| New | +$412K |
|
82
UnitedHealth
UNH
$378B
| $362K | 0.41% |
766
+323
| +73% | +$156K |
|
83
Entegris
ENTG
$18.8B
| $351K | 0.4% |
4,275
-179
| -4% | -$14.5K |
|
84
Lowe's Companies
LOW
$117B
| $334K | 0.38% |
1,670
+114
| +7% | +$23.2K |
|
85
Broadridge
BR
$18.2B
| $329K | 0.37% |
2,244
+13
| +0.6% | +$1.86K |
|
86
Equitable Holdings
EQH
$13.2B
| $325K | 0.37% |
12,812
+4,308
| +51% | +$127K |
|
87
Ecolab
ECL
$78B
| $324K | 0.37% |
1,958
+322
| +20% | +$50.2K |
|
88
Air Products & Chemicals
APD
$64.8B
| $317K | 0.36% |
1,103
-87
| -7% | -$25.4K |
|
89
Upbound Group
UPBD
$1.17B
| $310K | 0.35% |
12,662
-174
| -1% | -$4.48K |
|
90
Alphabet (Google) Class A
GOOGL
$4.58T
| $306K | 0.35% |
2,951
+273
| +10% | +$26.2K |
|
91
US Bancorp
USB
$99B
| $303K | 0.34% |
8,416
+331
| +4% | +$14.7K |
|
92
Markel Group
MKL
$23.2B
| $298K | 0.34% |
233
+30
| +15% | +$39.9K |
|
93
Revvity
RVTY
$12.8B
| $286K | 0.32% |
2,148
+254
| +13% | +$33.5K |
|
94
Procter & Gamble
PG
$337B
| $284K | 0.32% |
1,910
+149
| +8% | +$21.3K |
|
95
Alliant Energy
LNT
$18.3B
| $274K | 0.31% |
5,122
| – | – |
|
|
96
Robert Half
RHI
$4B
| $270K | 0.31% |
+3,353
| New | +$266K |
|
97
Quanta Services
PWR
$102B
| $243K | 0.28% |
1,458
+41
| +3% | +$6.3K |
|
98
Visa
V
$683B
| $233K | 0.26% |
+1,035
| New | +$230K |
|
99
Evergy
EVRG
$19.1B
| $230K | 0.26% |
3,761
| – | – |
|
100
PureCycle Technologies
PCT
$1.4B
| $228K | 0.26% |
32,563
+5,872
| +22% | +$40.9K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, First National Advisers held 114 positions worth $88.2M, up 13% from $78.1M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
First National Advisers deployed $4.72M of net new capital in Q1 2023, opening 6 new positions and adding to 84 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 5,416 shares worth $793K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $749K trimmed.
- First National Advisers's largest Q1 2023 buy was Jazz Pharmaceuticals: 5,416 shares worth $793K.
- First National Advisers added most to Abbott in Q1 2023, an estimated $402K increase.
- First National Advisers's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $749K.
- First National Advisers fully exited Corpay in Q1 2023, selling an estimated $635K.
- First National Advisers's ten largest holdings make up 28% of its $88.2M portfolio in Q1 2023.
- First National Advisers opened 6 new positions and closed 4 in Q1 2023.
- First National Advisers's portfolio value rose 13% quarter-over-quarter to $88.2M.
Based on First National Advisers's 13F filing for Q1 2023, filed 10 May 2023.